September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Individualized normal limits of retinal nerve fiber layer measurement reduce false positive test results in healthy subject
Author Affiliations & Notes
  • Clemens Vass
    Ophthalmology, Medical University of Vienna, Vienna, Austria
  • Ivania Pereira
    Ophthalmology, Medical University of Vienna, Vienna, Austria
    Center for Medical Statistics Informatics and Intelligent Systems, Section for Medical Information Management and Imaging, Medical University of Vienna, Vienna, Austria
  • Georg Fischer
    Center for Medical Statistics Informatics and Intelligent Systems, Section for Medical Information Management and Imaging, Medical University of Vienna, Vienna, Austria
  • Hemma Resch
    Ophthalmology, Medical University of Vienna, Vienna, Austria
  • Florian Schwarzhans
    Center for Medical Statistics Informatics and Intelligent Systems, Section for Medical Information Management and Imaging, Medical University of Vienna, Vienna, Austria
  • Stephan Holzer
    Ophthalmology, Medical University of Vienna, Vienna, Austria
  • Footnotes
    Commercial Relationships   Clemens Vass, Carl Zeiss Meditec (R), Heidelberg Engineering (R); Ivania Pereira, None; Georg Fischer, None; Hemma Resch, None; Florian Schwarzhans, None; Stephan Holzer, None
  • Footnotes
    Support  The study was funded by: Wiener Wissenschafts-, Forschungs- and Technologiefonds, WWTF – LS11-046
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 850. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Clemens Vass, Ivania Pereira, Georg Fischer, Hemma Resch, Florian Schwarzhans, Stephan Holzer; Individualized normal limits of retinal nerve fiber layer measurement reduce false positive test results in healthy subject. Invest. Ophthalmol. Vis. Sci. 2016;57(12):850.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Recently we have shown that a compensation formula based on multiple linear regression analysis reduced the interindividual variation of retinal nerve fiber layer (RNFL) measurement by 18% on average. This regression model can be applied to generate patient specific individualized normal limits (INL). The purpose of the present study is to analyze whether the number of false positive (FP) sectors or the number of subjects displaying FP sectors is reduced when using INL as opposed to group normal limits (GNL).

Methods : This is a retrospective analysis of 202 healthy subjects having been collected for another prospective study. All subjects underwent FD-OCT (Cirrus ®, Carl Zeiss Meditec) of the macula and the circumpapillary area. The retinal vessels was automatically segmented using both scanning protocols, and the vessel thickness values at a 3.4 mm diameter circle were used to calculate the retinal vessel density function (RVD). The RVD reflects the locations and thickness values of the retinal vessels according to a Gaussian convolution. The factors considered for multiple linear regression were: RVD, distance between fovea and optic disk (OD) center, fovea angle, OD size, OD ratio (=elongation), OD angle and refractive error. The normal limits were calculated twice: for the GNL we used our sample’s mean values and standard deviations, and for the INL we applied the regression formula, using the RNFL estimate and the variance of the model. For each clock hour sector we evaluated the number below the 5% normal limit (NL5), or below the 1% normal limit (NL1). We also evaluated the number of subjects with at least one sector below NL5 or NL1. The reduction of the number of FP sectors and subjects when applying the INL, as opposed to the GNL was compared using Chi-square tests.

Results : The number of clock hour sectors below the NL5 and NL1 was reduced from 82 to 23 (p<0.00001) and from 13 to 1 (p=0.00132) out of 2424 sectors for the patient specific INL compared to the GNL. The number subjects with at least one sector below NL5 and NL1 was reduced from 48 to 19 (p=0.00010) and from 12 to 1 (p=0.00187) out of 202 subjects.

Conclusions : Application of patient specific INL resulted in a very pronounced reduction of FP sectors and of subjects with FP sectors, compared to standard GNL.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×